Ebidco has completed a voluntary public tender offer for the warrants of Eles Semiconductor Equipment
Ebidco S.r.l. has completed a voluntary public tender offer for the warrants of Eles Semiconductor Equipment S.p.A.
Ebidco is an acquisition vehicle owned by Xenon Private Equity. It was established for the purpose of acquiring the warrants of Eles Semiconductor Equipment through a tender offer.
Eles Semiconductor Equipment specializes in the design and manufacture of performance test systems and equipment for the semiconductor industry. The company offers solutions for assessing the reliability of semiconductor integrated circuits and electronic modules. It is also involved in test system configuration and engineering activities. Given its status as a publicly listed company, the warrants of Eles Semiconductor Equipment had a widely dispersed shareholder base.
Oaklins Italy’s parent company, Banca Akros, served as the appointed broker for the collection of warrants in Ebidco’s voluntary public tender offer for 100% of Eles Semiconductor Equipment’s warrants.
Talk to the deal team
Related deals
F.EE has been acquired by One Equity Partners
F.EE GmbH, one of Germany’s leading providers of innovative solutions in mechanical engineering, automation hardware, cabinet control, software and robot programming, has been acquired by One Equity Partners. This transaction will strengthen the private equity firm’s operations in the industrial automation space. The sellers have reinvested and will remain involved in the business for the coming years.
Learn moreSRT Marine has completed a placing and subscription
SRT Marine Systems plc has announced an equity raise of at least US$22 million at US$1.10 per share representing a 5.75% discount, through a US$19.4 million accelerated bookbuild placing and a US$2 million subscription by Ocean Infinity, alongside a separate retail offer of up to US$1.3 million.
Learn moreIXICO has completed a fundraising
IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.
Learn more